Leitragin Increases Transcription of Sirtuin 6 Gene under Conditions of Acute Lung In flammation in Mice

Sirtuins are NAD-dependent class III histone deacetylases, represented in mammals by seven isoforms that differ in substrate specificity and intracellular localization. Nuclear sirtuins 1 (SIRT1) and 6 (SIRT6) deacetylate components of pro-inflammatory signaling pathways, playing a key role in the resolution of inflammation. Leitragin, a peptide agonist of δ-opioid receptors, is a representative of a new promising class of anti-inflammatory drugs, whose known mechanism of action is associated with the activation of SIRT1 transcription. The aim of this study was to investigate the effect of inhaled Leitragin on the transcription of all seven isoforms of mammalian sirtuins in the lungs of C57BL/6Y mice under conditions of acute lung inflammation and ARDS modeling. This study is the first to demonstrate that inhalation of Leitragin significantly increases SIRT6 transcription in the lungs, in addition to the previously known effect of activating SIRT1 transcription under inflammatory conditions. This work clarifies the anti-inflammatory action of Leitragin, which involves the upregulation of SIRT1 and SIRT6 transcription, known negative regulators of pro-inflammatory signaling pathways where the NF-κB transcription factor plays a key role.

1. Karkischenko V.N., Pomytkin I.A., Petrova N.V., Gasanov M.T., Nes terov M.S., Fokin Yu.V., Alimkina O.V., Hvostov D.V. Lejtragin povishaet vijivaemost zhivotnih v modeli fatalnogo ostrogo respiratornogo distress-sindroma pri profilacticheskom i lechebnom rezhimah vvedeni ya [Leitragin increases animal survival in a model of fatal acute respiratory distress syndrome under pro phylactic and therapeutic modes of administration]. Biomedicina [Journal Biomed]. 2020;16(4):44–51. (In Russian). DOI: 10.33647/2074-5982-16-4-44-51.

2. Karkischenko V.N., Pomytkin I.A., Petrova N.V., Nesterov M.S., Ageldinov R.A., Zotova L.V., Koloskova E.M., Slobodenyuk V.V., Skvortsova V.I. Lejtragin podavlyaet ekspressiyu citokinov, vklyucha ya interlejkin-6, v modeli «citokinovogo shtorma» u myshej linii C57BL/6Y s inducirovannym ostrym respiratornym distress-sindromom [Leitragin Inhibits Expression of Cytokines, Including Interleukin-6, in a “Cytokine Storm” Model in C57BL/6Y Mice with Induced Acute Respiratory Distress Syndrome]. Biomedicina [Journal Biomed]. 2020;16(4):34–43. (In Russian). DOI: 10.33647/2074-5982-16-4-34-43.

3. Pomytkin I.A., Ogneva N.S., Fokin Yu.V., Petrova N.V., Alimkina O.V., Karkischenko V.N. Epigeneticheskie mehanizmi protivovospalitelnogo deistviya opioid nogo peptide Lejtragin: rol sirtuina 1. [Epigenetic mechanisms of the anti-inflammatory action of the opioid peptide Leitragin: role of sirtuin 1]. Biomedicina [Journal Biomed]. 2024;20(3):10–20. (In Russian). DOI: 10.33647/2074-5982-20-3-10-20.

4. Rukovodstvo po labo ratornym zhivotnym i al'ternativnym modelyam v bio medicinskih issledovaniyah [A Guide to Laboratory Animals and Alternative Models in Biomedical Research]. Ed. by N.N. Karkischenko, S.V. Grachev. Moscow: Profil`-2C Publ., 2010:358. (In Russian).

5. Rukovodstvo po provedeniyu doklinicheskih issledovanij lekarstvennyh sredstv. Chast' pervaya [Guidelines for conducting pre clinical studies of drugs. Part one]. Ed. by A.N. Mironov. Moscow: Grif i K Publ., 2012:944. (In Russian).

6. Chen G.D., Yu W.D., Chen X.P. Sirt1 activator represses the transcription of TNF-α in THP-1 cells of a sepsis model via deacetylation of H4K16. Mol. Med. Rep. 2016;14(6):5544–5550. DOI: 10.3892/mmr.2016.5942.

7. Fu D., Liu H., Zhu J., Xu H., Yao J. [D-Ala2, D-Leu5] Enkephalin Inhibits TLR4/NF-κB Signaling Pathway and Protects Rat Brains against Focal Ischemia-Reperfusion Injury. Mediators Inflamm. 2021;2021:6661620. DOI: 10.1155/2021/6661620.

8. Kang R., Chen R., Zhang Q., Hou W., Wu S., Cao L., Huang J., Yu Y., Fan X.G., Yan Z., Sun X., Wang H., Wang Q., Tsung A., Billiar T.R., Zeh H.J. 3rd, Lotze M.T., Tang D. HMGB1 in health and disease. Mol. Aspects Med. 2014;40:1–116. DOI: 10.1016/j.mam.2014.05.001.

9. Karkischenko V.N., Skvortsova V.I., Gasanov M.T., Fokin Y.V., Nesterov M.S., Petrova N.V., Alimkina O.V., Pomytkin I.A. Inhaled [D-Ala2]-Dynorphin 1-6 Prevents Hyperacetylation and Release of High Mobility Group Box 1 in a Mouse Model of Acute Lung Injury. J. Immunol. Res. 2021;2021:4414544. DOI: 10.1155/2021/4414544.

10. Kawahara T.L., Michishita E., Adler A.S., Damian M., Berber E., Lin M., McCord R.A., Ongaigui K.C., Boxer L.D., Chang H.Y., Chua K.F. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell. 2009;136(1):62–74. DOI: 10.1016/j.cell.2008.10.052.

11. Kiernan R., Brès V., Ng R.W., Coudart M.P., El Messaoudi S., Sardet C., Jin D.Y., Emiliani S., Benkirane M. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetyla tion of p65. J. Biol. Chem. 2003;278(4):2758–2766. DOI: 10.1074/jbc.M209572200.

12. Morris B.J. Seven sirtuins for seven deadly diseases of aging. Free Radic. Biol. Med. 2013;56:133–171. DOI: 10.1016/j.freeradbiomed.2012.10.525.

13. Rabadi M.M., Xavier S., Vasko R., Kaur K., Goligorksy M.S., Ratliff B.B. High-mobility group box 1 is a novel deacetylation target of Sirtuin1. Kidney Int. 2015;87(1):95–108. DOI: 10.1038/ki.2014.217.

14. Tang C.W., Feng W.M., Du H.M., Bao Y., Zhu M. Delayed administration of D-Ala2-D-Leu5-enkepha lin, a delta-opioid receptor agonist, improves sur vival in a rat model of sepsis. Tohoku J. Exp. Med. 2011;224(1):69–76. DOI: 10.1620/tjem.224.69.

15. Yang Y., Liu Y., Wang Y., Chao Y., Zhang J., Jia Y., Tie J., Hu D. Regulation of SIRT1 and Its Roles in Inflammation. Front. Immunol. 2022;13:831168. DOI: 10.3389/fimmu.2022.831168.

16. Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R., Frye R.A, Mayo M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004;23(12):2369 2380. DOI: 10.1038/sj.emboj.7600244.

17. Zhang Y., Li Y., Li J., Li B., Chong Y., Zheng G., Sun S., Feng F. SIRT1 alleviates isoniazid-induced hepatocyte injury by reducing histone acetylation in the IL-6 pro moter region. Int. Immunopharmacol. 2019;67:348 355. DOI: 10.1016/j.intimp.2018.11.054.